ArticleFrontiers in genetics2026
Exploration of candidate genes associated with rare SNVs in pulmonary stenosis using whole-exome sequencing and machine learning.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary stenosis (PS) is a common form of congenital heart disease (CHD) that impairs cardiopulmonary function and can be life-threatening in severe cases. As a complex polygenic disorder, the genetic basis of PS remains incompletely understood. Methods: Rare pathogenic single nucleotide variants (SNVs) were identified from whole-exome sequencing (WES) data of 185 sporadic PS patients and 100 healthy controls using multiple pathogenicity-filtering strategies. Gene-level burden test was performed, with complementary analysis using sequence kernel association test-optimal (SKAT-O). Three machine learning algorithms-least absolute shrinkage and selection operator (LASSO), random forest (RF), and extreme gradient boosting (XGBoost)-were applied to prioritize candidate genes. The overlap between machine learning-based selections and burden test results was systematically evaluated. Final candidate genes were further prioritized through protein-protein interaction (PPI) network analysis, and their expression in human pulmonary artery endothelial cells (HPAECs) was assessed by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: Comparative analyses showed that different machine learning algorithms exhibited distinct feature selection patterns, with RF demonstrating the highest concordance with burden test results. A total of 17 candidate genes were prioritized ( Conclusion: These findings indicate that machine learning can complement conventional gene-based analyses of WES data. This study provides a set of candidate genes associated with PS and offers a basis for further investigation of its genetic architecture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.